HomeCompareNHKFF vs RYLD

NHKFF vs RYLD: Dividend Comparison 2026

NHKFF yields 557.10% · RYLD yields 12.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NHKFF wins by $174318500157098033152.00M in total portfolio value
10 years
NHKFF
NHKFF
● Live price
557.10%
Share price
$0.36
Annual div
$2.00
5Y div CAGR
95.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$174318500157098033152.00M
Annual income
$174,243,062,167,289,250,000,000,000.00
Full NHKFF calculator →
RYLD
RYLD
● Live price
12.14%
Share price
$14.95
Annual div
$1.81
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.5K
Annual income
$2,587.35
Full RYLD calculator →

Portfolio growth — NHKFF vs RYLD

📍 NHKFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNHKFFRYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NHKFF + RYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NHKFF pays
RYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NHKFF
Annual income on $10K today (after 15% tax)
$47,353.76/yr
After 10yr DRIP, annual income (after tax)
$148,106,602,842,195,860,000,000,000.00/yr
RYLD
Annual income on $10K today (after 15% tax)
$1,031.60/yr
After 10yr DRIP, annual income (after tax)
$2,199.25/yr
At 15% tax rate, NHKFF beats the other by $148,106,602,842,195,860,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NHKFF + RYLD for your $10,000?

NHKFF: 50%RYLD: 50%
100% RYLD50/50100% NHKFF
Portfolio after 10yr
$87159250078549016576.00M
Annual income
$87,121,531,083,644,620,000,000,000.00/yr
Blended yield
99.96%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NHKFF buys
0
RYLD buys
0
No recent congressional trades found for NHKFF or RYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNHKFFRYLD
Forward yield557.10%12.14%
Annual dividend / share$2.00$1.81
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR95.5%0%
Portfolio after 10y$174318500157098033152.00M$44.5K
Annual income after 10y$174,243,062,167,289,250,000,000,000.00$2,587.35
Total dividends collected$174313561310925258752.00M$18.8K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: NHKFF vs RYLD ($10,000, DRIP)

YearNHKFF PortfolioNHKFF Income/yrRYLD PortfolioRYLD Income/yrGap
1← crossover$119,614$108,913.65$11,914$1,213.65+$107.7KNHKFF
2$2,508,256$2,380,268.96$14,099$1,351.30+$2.49MNHKFF
3$93,880,730$91,196,896.77$16,580$1,494.55+$93.86MNHKFF
4$6,337,049,933$6,236,597,552.02$19,384$1,642.61+$6337.03MNHKFF
5$775,948,938,114$769,168,294,685.67$22,535$1,794.70+$775948.92MNHKFF
6$172,910,255,380,782$172,079,990,016,999.80$26,063$1,950.00+$172910255.35MNHKFF
7$70,246,761,459,188,210$70,061,747,485,930,776.00$29,995$2,107.69+$70246761459.16MNHKFF
8$52,080,691,335,612,070,000$52,005,527,300,850,740,000.00$34,361$2,266.99+$52080691335612.04MNHKFF
9$70,502,794,213,834,740,000,000$70,447,067,874,105,630,000,000.00$39,194$2,427.12+$70502794213834736.00MNHKFF
10$174,318,500,157,098,050,000,000,000$174,243,062,167,289,250,000,000,000.00$44,525$2,587.35+$174318500157098033152.00MNHKFF

NHKFF vs RYLD: Complete Analysis 2026

NHKFFStock

Nichi-Iko Pharmaceutical Co., Ltd. manufactures, sells, and distributes various pharmaceutical products. It operates through two segments, Nichi-Iko Group and Sagent Group. The company primarily focuses on the production of generic drugs. It offers antidiabetic agents, antacids, antireflux agents, beta-blocker, hypnotic and sedative, angiotensin ? antagonist, angiotensin ? antagonist/diuretic combination, dyslipidaemic agent, and calcium antagonist products, as well as chemotherapeutic agents. The company also provides treatments for circulatory, digestive, respiratory, nervous system, allergies, and others. It supplies its products to medical institutions, including hospitals, clinics, dispensing pharmacies, etc. The company was formerly known as Nihon Iyakuhin Kogyo Co., Ltd. and changed its name to Nichi-Iko Pharmaceutical Co., Ltd. in 2005. Nichi-Iko Pharmaceutical Co., Ltd. was incorporated in 1947 and is headquartered in Toyama, Japan.

Full NHKFF Calculator →

RYLDETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →
📬

Get this NHKFF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NHKFF vs SCHDNHKFF vs JEPINHKFF vs ONHKFF vs KONHKFF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.